Safety of Factor XIII Concentrate: Analysis of More than 20 Years of Pharmacovigilance Data

Plasma-derived factor XIII (FXIII) concentrate is an effective treatment for FXIII deficiency. We describe adverse drug reactions (ADRs) reported during pharmacovigilance monitoring of Fibrogammin？/Corifact？ and review published safety data